ELVN logo

Enliven Therapeutics, Inc. (ELVN) Accounts payable

annual accounts payable:

$1.34M+$810.00K(+152.26%)
December 31, 2024

Summary

  • As of today (July 11, 2025), ELVN annual accounts payable is $1.34 million, with the most recent change of +$810.00 thousand (+152.26%) on December 31, 2024.
  • During the last 3 years, ELVN annual accounts payable has fallen by -$1.18 million (-46.77%).
  • ELVN annual accounts payable is now -60.97% below its all-time high of $3.44 million, reached on December 31, 2022.

Performance

ELVN Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNbalance sheet metrics

quarterly accounts payable:

$1.56M+$220.00K(+16.39%)
March 31, 2025

Summary

  • As of today (July 11, 2025), ELVN quarterly accounts payable is $1.56 million, with the most recent change of +$220.00 thousand (+16.39%) on March 31, 2025.
  • Over the past year, ELVN quarterly accounts payable has dropped by -$1.17 million (-42.72%).
  • ELVN quarterly accounts payable is now -73.34% below its all-time high of $5.86 million, reached on March 31, 2023.

Performance

ELVN quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ELVN Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+152.3%-42.7%
3 y3 years-46.8%-
5 y5 years+66.1%-38.0%

ELVN Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-61.0%+152.3%-73.3%+193.6%
5 y5-year-61.0%+152.3%-73.3%+193.6%
alltimeall time-61.0%+152.3%-73.3%+193.6%

ELVN Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$1.56M(+16.4%)
Dec 2024
$1.34M(+152.3%)
$1.34M(+31.7%)
Sep 2024
-
$1.02M(-5.9%)
Jun 2024
-
$1.08M(-60.3%)
Mar 2024
-
$2.73M(+412.6%)
Dec 2023
$532.00K
$532.00K(-64.4%)
Sep 2023
-
$1.49M(-47.5%)
DateAnnualQuarterly
Jun 2023
-
$2.84M(-51.5%)
Mar 2023
-
$5.86M(+70.4%)
Dec 2022
$3.44M(+36.4%)
$3.44M(+14.9%)
Sep 2022
-
$2.99M(+18.7%)
Dec 2021
$2.52M(+212.0%)
-
Dec 2021
-
$2.52M
Dec 2020
$808.00K
-

FAQ

  • What is Enliven Therapeutics, Inc. annual accounts payable?
  • What is the all time high annual accounts payable for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual accounts payable year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly accounts payable year-on-year change?

What is Enliven Therapeutics, Inc. annual accounts payable?

The current annual accounts payable of ELVN is $1.34M

What is the all time high annual accounts payable for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual accounts payable is $3.44M

What is Enliven Therapeutics, Inc. annual accounts payable year-on-year change?

Over the past year, ELVN annual accounts payable has changed by +$810.00K (+152.26%)

What is Enliven Therapeutics, Inc. quarterly accounts payable?

The current quarterly accounts payable of ELVN is $1.56M

What is the all time high quarterly accounts payable for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly accounts payable is $5.86M

What is Enliven Therapeutics, Inc. quarterly accounts payable year-on-year change?

Over the past year, ELVN quarterly accounts payable has changed by -$1.17M (-42.72%)
On this page